Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proactive versus reactive inhibition in ADHD
2012-000992-18Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University Medical Center Utrecht. Primary endpoints: Stop-associated ERP N1 amplitude and/or latency at baseline and Stop-associated ERP P3 amplitude and/or latency at baseline. Started Jan 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2012-000992-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000992-18.